| 1.
|
Describe the following nonorgan imaging studies to include combined
liver/lung, breast, dacroscintigraphy, radionuclide venography,
antibody imaging, in-vitro, LeVeen shunt procedures, and other special
organ systems. (I)
|
| 2.
|
Describe the specific pathology treated through therapeutic nuclear
medicine techniques to include hyperthyroidism,thyroid carcinoma,
euthyroid heart disease, polycythemia vera, chronic leukemia,
malignant lymphoma, metastatic bone disease, malignant pericardial
effusion, malignant peritoneal effusion, malignant pleural effusion,
ovarian carcinoma, and other forms of pathology. (II)
|
| 3.
|
Describe the indications, preparation, quality control, and biological
behavior of the radiopharmaceuticals used in nuclear medicine
therapeutic procedures. (III)
|
| 4.
|
Explain nuclear medicine therapeutic procedures to include patient
preparation, personnel and laboratory preparation, administration of
the radiopharmaceutical, post-therapeutic procedures, special
considerations, and radiation safety. (IV)
|
| 5.
|
Describe fundamental principles of Positron Emission Tomography
(P.E.T.) imaging to include theory, equipment, radiopharmaceuticals,
indications, and applications. (V)
|
| 6.
|
Describe other imaging modalities to include radiography, ultrasound,
computerized tomography, and magnetic resonance. (VI)
|
|